BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25980755)

  • 1. Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.
    Bharucha AE; Batey-Schaefer B; Cleary PA; Murray JA; Cowie C; Lorenzi G; Driscoll M; Harth J; Larkin M; Christofi M; Bayless M; Wimmergren N; Herman W; Whitehouse F; Jones K; Kruger D; Martin C; Ziegler G; Zinsmeister AR; Nathan DM;
    Gastroenterology; 2015 Aug; 149(2):330-9. PubMed ID: 25980755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed Gastric Emptying Associates With Diabetic Complications in Diabetic Patients With Symptoms of Gastroparesis.
    Parkman HP; Wilson LA; Farrugia G; Koch KL; Hasler WL; Nguyen LA; Abell TL; Snape W; Clarke J; Kuo B; McCallum RW; Sarosiek I; Grover M; Miriel L; Tonascia J; Hamilton FA; Pasricha PJ;
    Am J Gastroenterol; 2019 Nov; 114(11):1778-1794. PubMed ID: 31658129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Lenherr SM; Clemens JQ; Braffett BH; Dunn RL; Cleary PA; Kim C; Herman WH; Hotaling JM; Jacobson AM; Brown JS; Wessells H; Sarma AV;
    Diabet Med; 2016 Nov; 33(11):1528-1535. PubMed ID: 27028025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
    Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
    Sousa GR; Pober D; Galderisi A; Lv H; Yu L; Pereira AC; Doria A; Kosiborod M; Lipes MA
    Circulation; 2019 Feb; 139(6):730-743. PubMed ID: 30586738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed gastric emptying rate in Type 1 diabetics with cardiac autonomic neuropathy.
    Darwiche G; Almér LO; Björgell O; Cederholm C; Nilsson P
    J Diabetes Complications; 2001; 15(3):128-34. PubMed ID: 11358681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
    Genuth SM; Backlund JY; Bayless M; Bluemke DA; Cleary PA; Crandall J; Lachin JM; Lima JA; Miao C; Turkbey EB;
    Diabetes; 2013 Oct; 62(10):3561-9. PubMed ID: 23520132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of delayed gastric emptying among Indian patients with long-standing type 2 diabetes mellitus.
    Anudeep V; Vinod KV; Pandit N; Sharma VK; Dhanapathi H; Dutta TK; Sujiv A
    Indian J Gastroenterol; 2016 Sep; 35(5):385-392. PubMed ID: 27667549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 Antagonist.
    Chakraborty S; Halland M; Burton D; Desai A; Neja B; Low P; Singer W; Camilleri M; Zinsmeister AR; Bharucha AE
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1967-1977. PubMed ID: 30358871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
    Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV;
    Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
    Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
    Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
    Bebu I; Braffett BH; Pop-Busui R; Orchard TJ; Nathan DM; Lachin JM;
    Diabetologia; 2017 Oct; 60(10):2084-2091. PubMed ID: 28711972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.